Autism spectrum disorders (ASD) comprise a heterogeneous group of neurodevelopmental disorders characterized by complex genetic etiology. Mutations in human APBA2, which encodes for the neuronal adaptor protein Mint2, have been genetically linked to ASD patients. APBA2 maps to the distal portion of chromosome 15q13.1, a region commonly deleted in Prader-Willi and Angelman neurodevelopmental disorders and duplicated in cases of autism, making APBA2 an attractive candidate gene associated with autism. Seven novel nonsynonymous coding variants in APBA2 in ASD subjects have been identified, five of which were predicted to affect protein function; however, they have not been examined functionally. Mint2 belongs to a family of neuronal adaptor proteins that are important for synaptic function. Mint2 interacts directly with the cell adhesion protein neurexin-1α, as part of a multi-protein complex that acts as a facilitator of neurotransmitter release. Together, these data suggest that Mint2 plays an important role in neuronal function, and sequence variations in Mint2 may alter neuronal dysfunction associated with ASD. This thesis examines a point mutation in Mint2, which changes a conserved asparagine residue to a serine (N723S) in the second PDZ domain of Mint2, which binds to neurexin-1α. We found the Mint2 N723S mutation did not affect the binding to neurexin-1α; however, it dramatically altered neurexin-1α stabilization and trafficking in HEK293T cells. While Mint2 wild type greatly increased neurexin-1α at the membrane, Mint2 N723S showed a decreased membrane level of neurexin-1α, indicating the steady-state surface expression of neurexin is affected by the Mint2 N723S mutation. Also, we found that Mint2 N723S decreased neurexin localization in axons and the presynaptic terminal in neurons, which correlated with a decrease in synaptogenesis and miniature event frequency in excitatory synapses in neurons. Together, these results suggest that Mint2 N723S leads to dysfunction in neuronal development, in part due to alterations in intracellular neurexin trafficking and altered synaptic function of Mint2, as potential mechanisms that contribute to ASD pathogenesis. / 2018-11-01T00:00:00Z

Major mental illness is now recognised as one of the leading causes of adult morbidity. Of the adult onset psychiatric disorders, the functional psychoses (schizophrenia, bipolar disorder and recurrent major depression) are the most severe and most common in the general population. Evidence suggests that certain genetic factors influence an individual’s susceptibility to developing these disorders when combined with appropriate social and environmental conditions. Several good candidate genes have been identified. Of relevance to this study is Disrupted in Schizophrenia 1 (DISC1) which was identified in a large Scottish family that carried a balanced translocation (t1:11) and had a history of major mental illness. In 2008, two ENU mutant mouse models with missense mutations in exon 2 of Disc1 were characterised and found to have behavioural and neuroanatomical phenotypes consistent with schizophrenia and major depression. The primary aim of this thesis is to further analyse these mouse models by performing whole genome gene expression studies and secondary protein analysis to identify genes involved in the aetiology of schizophrenia and major depression. My initial analysis used Illumina BeadChip microarray technology to identify 368 genes that were differentially expressed in ENU mutant animals under different biological conditions, compared to appropriate control animals. Nine biological groups were compared including one embryonic group at E13, and three groups treated with appropriate anti-psychotic or anti-depressant drugs. Of the 368 genes identified as differentially expressed, 46 were chosen for validation by qRT-PCR based on fold-change, p-value, functional significance, overenrichment of GO terms, pathway analysis and previous implications in major mental illness. NRXN1, NRXN3 and CDH11 were found to be significantly up-regulated in the schizophrenia mouse model with EGR4 significantly down-regulated compared to C57BL/6J wild-type controls. These findings were also replicated in an independent sample using wildtype littermates. The mental retardation gene PAK3 was up-regulated in the schizophrenia mouse model and expression levels were corrected to a level not significantly different to wild-type, when treated with the PDE4 inhibitor Rolipram. Semi-quantitative western blotting also confirmed the disregulation of EGR4 and PAK3 at the protein level in these animals. RNA expression profiles were also characterised for each of the genes above, and DISC1, through development. In summary this thesis describes the striking disregulation of four prominent genetic candidates of major mental illness in an independent animal model. A first functional link between DISC1 and NRXN1 is described suggesting, for the first time, a DISC1- dependant mechanism for regulating neurexin gene expression.

No description available.

Indiana University-Purdue University Indianapolis (IUPUI) / Neurexin I alpha (NRXN1α) and Dystroglycan (DAG1) are membrane receptors which serve as mutual ligands in the neuronal system. Neurexophilins (NXPHs) bind NRXN1α. Both NRXN1α and DAG1 were expressed in primitive populations in human cord blood (huCB) and murine bone marrow (muBM), with high concentrations of NXPHs in huCB plasma. We evaluated effects of these molecules on huCB and muBM hematopoietic progenitor (HPC) and stem (HSC) cells. At both a single and population level in vitro, we found that NXPH1 is a potent inhibitor of HPC proliferation acting through NRXN1α, an effect antagonized by DAG1. Injection of recombinant NXPH1 in vivo resulted in myelo- and lymphosuppression, with absolute numbers and cycling status of functional and phenotypically defined HPCs dose- and time-dependently decreased, and absolute numbers and cycling status of phenotypically defined longer-term repopulation HSCs increased. Competitive transplants showed an initial decrease in engraftment of NXPH1-treated cells, with an intermediate stage increase in engraftment. The increase in HSCs is at least partially mediated by the mTOR pathway and is thought to be homeostatic in nature. These results demonstrate the presence and function of a regulated signaling axis in hematopoiesis centered on NRXN1α and its modulation by DAG1 and NXPH1.

No description available.

Dans le système nerveux central, la synaptogenèse est un processus complexe multi-étapes qui se déroule aux contacts axones/dendrites. Les molécules d’adhérence neurexines/neuroligines jouent un rôle essentiel dans ce processus, en créant un lien physique entre les compartiments pré- et post-synaptiques et en participant au recrutement des complexes macromoléculaires essentiels à la fonction synaptique. Plus spécifiquement, le complexe neurexine-1β/neuroligine-1 induit la formation de post-synapses excitatrices, en recrutant des molécules d’échafaudage telles que PSD-95 et des récepteurs du glutamate.Mon travail de thèse a consisté à étudier les mécanismes moléculaires mis en jeu par les adhésions neurexines/neuroligines lors de la formation des post-synapses glutamatergiques. En utilisant des systèmes biomimétiques (neurexine purifiée fixée sur des billes, ou agrégée par des anticorps réticulés), nous avons induit des adhésions spécifiques neurexine-1β/neuroligine-1 sur des neurones d’hippocampe en culture. Nous avons ainsi étudié la distribution dynamique des composants post-synaptiques (récepteurs AMPA, PSD-95) endogènes ou étiquetés avec des protéines fluorescentes, par vidéo-microscopie. Dans un premier article, nous avons montré que la formation de ces contacts induisait un recrutement rapide de PSD-95 ainsi que des récepteurs NMDA et AMPA fonctionnels. En utilisant des récepteurs AMPA recombinants, j’ai montré que ce recrutement était dicté par la sous-unité GluA2. Dans une deuxième étude, en comparant le recrutement de PSD-95 induit par la neurexine avec des anticorps non–activants, nous avons mis en évidence un mécanisme d’activation spécifique de neuroligine-1 induit par la liaison de neurexine-1β. L’utilisation de mutants ponctuels de neuroligine-1 a permis de montrer que cette activation passe probablement par la déphosphorylation d’une tyrosine unique située dans le domaine C-terminal de la neuroligine-1.Enfin, en étudiant la diffusion latérale des rAMPA de surface par suivi de particules uniques fluorescentes (Quantum dots), ainsi qu’une batterie d’outils moléculaires pour moduler les adhésions neurexine/neuroligine (sur-expression, siRNA, souris KO), nous avons montré que les rAMPA sont recrutés aux adhésions neurexine-1β/neuroligine-1 via l’échafaudage PSD-95 et que ce recrutement nécessite la diffusion des récepteurs dans la membrane plasmique. Nous proposons ainsi que les récepteurs AMPA soient recrutés aux contacts naissants via un mécanisme original de diffusion/piégeage. / In the central nervous system, synaptogenesis is a multi step process occuring at axo-dendritic contacts. Neurexins/neuroligins adhesions are particularly involved in this process, making a bridge between the pre- and the post-synapse, and participating to the recruitment of macromolecular complexes essential for synaptic function. More precisely neurexin-1β/neuroligin-1 complex is specifically involved in the formation of excitatory synapses, inducing the recruitment of glutamatergic post-synapses components, such as PSD-95, and glutamate receptors.During my PhD, I focused on the molecular mechanisms involved in glutamatergic post-synapses formation triggered by neurexin-1β/neuroligin-1 adhesions. Using biomimetic models (beads coated with purified neurexin, or purified neurexin cross-linked with aggregated antibodies) we induced specific neurexin-1β/neuroligin-1 adhesions on cultured hippocampal neurons. We then studied the dynamic distribution of either endogenous or recombinant post-synaptic components (PSD-95, AMPARs) with live-imaging techniques. First, we showed that the formation of these contacts induced a rapid recruitment of PSD-95 and functional NMDA and AMPA receptors. Using recombinant AMPA receptors, I showed that this recruitment was mediated by GluA2 subunit.In a second study, using systematic comparison between the recruitment of PSD-95 induced either by neurexin-1β or by “non activating” antibody binding on neuroligin-1, we revealed a specific activation mechanism of neuroligin-1 induced by neurexin-1β binding. Using point mutations on neuroligin-1, we showed that this activation mechanism is mediated by a tyrosine dephosphorylation on neuroligin-1 intracellular tail.Finally, we studied AMPA receptor surface diffusion with single particle tracking experiments, using different molecular tools to perturb neurexin-1β/neuroligin-1 adhesions (overexpression, RNA interference, KO mice). We showed that AMPA receptors recruitment at new-formed neurexin-1β/neuroligin-1 adhesions occurs through PSD-95, and involves surface diffusion of AMPA receptors. We proposed an original diffusion/trap mechanism of AMPA receptors at nascent contacts.

No description available.

Neuroligine (NL) sind vorwiegend postsynaptisch lokalisierte transmembrane Adhäsionsmoleküle, die in Wechselwirkung mit dem präsynaptisch lokalisierten Protein Neurexin eine wichtige Rolle in der Reifung und Funktion von Synapsen spielen. Es existieren verschiedene NL-Isoproteine (NL-1 – NL-4), die sich in ihrer Assoziation zu exzitatorischen und inhibitorischen Synapsen unterscheiden. Die funktionelle und klinische Relevanz der Neuroligine belegen beispielhaft Mutationen des Isotyps NL 4, welche mit neuropsychiatrischen Erkrankungen wie Autismus-Spektrum-Störungen assoziiert vorkommen. Anhand eines durch Ausschalten des human-orthologen NL-4-Gens generierten Mausmodells (NL 4 Knockout, NL 4 KO) konnte in vorhergehenden Studien die Bedeutung einer immunhistochemisch beobachteten Lokalisation von NL 4 an glycinergen Synapsen der Retina für die inhibitorische synaptische Übertragung nachgewiesen werden. Im Unterschied dazu konnte kein Zusammenhang zwischen einer in Schicht IV des Barrel-Kortex nachweisbaren Lokalisation von NL-4 mit inhibitorischen Synapsen hergestellt werden. Deshalb, und aufgrund der in Schicht IV dominierenden exzitatorischen Verschaltung von thalamischen Projektionen und den kolumnenassoziierten Rückverschaltungen aus dem Neokortex, lässt sich eine Interaktion von NL-4 mit exzitatorischen Synapsen in diesem Areal vermuten. Im Rahmen der vorliegenden Arbeit wurde anhand der NL-4-KO-Modellmaus der Frage nachgegangen, inwiefern NL-4 die exzitatorische synaptische Übertragung im Barrel-Kortex beeinflusst. Dafür wurden mit Hilfe der Patch-Clamp-Technik abgeleitete AMPA-Rezeptor-vermittelte exzitatorische postsynaptische Ströme (EPSC) von bedornten Sternzellen, Sternpyramiden- und Pyramidenzellen der Schicht IV ausgewertet und zwischen NL-4-Wildtyp- (NL 4-WT) und NL 4 KO-Neuronen verglichen. Dabei zeigten NL 4-KO-Neurone signifikant veränderte Parameter der EPSC-Kinetik. Die Abfallszeit war in NL 4 KO-Neuronen signifikant länger, das maximale Gefälle und die maximale Steigung signifikant flacher gegenüber NL-4-WT-Kontrollen. Diese Veränderungen sprechen für eine funktionelle Relevanz von NL-4 für die AMPA-Rezeptor-vermittelte synaptische Übertragung auf exzitatorische Neurone in Schicht IV des Barrel-Kortex. Das Muster der in NL-4-KO-Neuronen veränderten EPSC-Kinetik weist dabei auf eine Modulation der biophysikalischen AMPA-Rezeptoreigenschaften hin und könnte mit Veränderungen der synaptisch exprimierten AMPA-Rezeptor-TARP-Subtypen in Zusammenhang stehen, die über Proteine der postsynaptischen Dichte (wie PSD-95 und S SCAM) mit Neuroliginen interagieren.

Extensive serotonin (5-HT) fiber innervation throughout the brain corroborates 5-HT’s modulatory role in numerous behaviors including social behavior, emotion regulation, and learning and memory. Abnormal brain 5-HT levels and function are implicated in Autism Spectrum Disorder (ASD) which often co-occurs with other neuropsychiatric conditions. While 5-HT therapeutics are used to treat ASD, variable improvements in symptomatology require further investigation of 5-HT-mediated pathology. Neurexins (Nrxns) are presynaptic cell adhesion molecules that maintain synapse function for proper neural circuit assembly. Given that aberrant Nrxn and 5-HT function independently contribute to signaling pathology and behavioral impairments, it is critical to understand how Nrxn-mediated 5-HT neurotransmission participates in pathological mechanisms underlying ASD. Using fluorescence in situ hybridization, I found that the three Nrxn genes (Nrxn1, Nrxn2, and Nrxn3) are differentially expressed in 5-HT neurons in the dorsal raphe nucleus (DRN) and median raphe nucleus which contain the primary source of 5-HT neurons in the brain. Our lab generated a mouse model with selective deletion of Nrxns in 5-HT neurons to investigate the function of Nrxns in 5-HT signaling. The loss of Nrxns at 5-HT release sites reduced 5-HT release in the DRN and hippocampus and altered 5-HT innervation in specific brain regions. The lack of 5-HTergic Nrxns also reduced sociability and increased depressive-like behavior in males. This mouse model provides mechanisms to shed new light on 5-HT neurotransmission in the generation of complex behaviors.